Last reviewed · How we verify

NCT07528118: PDPH

Comparison of Acetaminophen With Aminophylline and Aminophylline With Dexamethasone for Prophylaxis of PDPH in Patients With History of PDPH.

Completed Phase 2 Last updated 14 April 2026
What this trial tests

Phase 2 trial testing Inj Aminophylline 100mg with Inj Acetaminophen 1000mg in 100ml Normal Saline in Post Dural Puncture Headache in 50 participants. Completed in 8 July 2024.

Timeline
1 August 2023
Primary endpoint
2 June 2024
8 July 2024

Quick facts

Lead sponsorSargodha Medical College
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment50
Start date1 August 2023
Primary completion2 June 2024
Estimated completion8 July 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Sargodha Medical College

Who can join

Adults 18 to 40, any sex, with Post Dural Puncture Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is hypothesized that there is a difference between intravenously administered aminophylline with intravenous acetaminophen and intravenously administered aminophylline with dexamethasone for prevention of and reducing severity of PDPH.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sargodha Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07528118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing